| abstract |
Compounds of formula (I) or salts thereof are disclosed: Where X is CH or N; Y is CR 5 or N; R 1 , R 2 , R 3 , R 4 , and R 5 are as defined herein. Also disclosed are methods of using such compounds that modulate or inhibit the enzymatic activity of hematopoietic progenitor cell kinase 1 (HPK1) and pharmaceutical compositions comprising such compounds. These compounds are useful in the treatment of viral infections and proliferative disorders, such as cancer. |